---
figid: PMC7312214__fchem-08-00516-g0001
figtitle: 'Innovative Potential of Statins in Cancer: New Targets for New Therapies'
organisms:
- Saccharomyces cerevisiae
- Oryza sativa
- Homo sapiens
- Mus musculus
- Gallus gallus
organisms_ner:
- Mus musculus
- Gallus gallus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7312214
filename: fchem-08-00516-g0001.jpg
figlink: pmc/articles/PMC7312214/figure/F1/
number: F1
caption: '(A) Schematic summary of Mevalonate Pathway (MVP) and chemical structure
  of HMGCR inhibitors mainly studied in cancer (simvastatin, lovastatin, pravastatin,
  fluvastatin, pitavastatin, atorvastatin and rosuvastatin); the pharmacophore moiety
  in red and the ring system moiety in blue). (B) Overview of the main molecular targets
  of statins in cancer. I Antiproliferative effect: statins inhibit the proliferation
  of cancer cell increasing ER stress markers GRP78 and ERp44, phosphorylating S6
  and 4EBP1 and inhibiting mTOR pathway (Okubo et al., ), and inhibiting HDACs (Lin
  et al., ; Chou et al., ). Statins involve LKB1-AMPK-p38MAPK-p53 survivin signaling
  cascade thanks to the phosphorylation and acetylation of p53 in cancer cells (Huang
  et al., ). II Pro-apoptotic effect: statins enhance apoptosis through inhibition
  of survivin protein expression (see above) (Huang et al., ), by inhibiting HIF-1α/PPAR-γ/PKM2-mediated
  glycolysis (Feng et al., ), induce caspase 3/7/8/9 protease, decrease the expression
  of cyclin D1 and CDK4 Bcl-XL (Okubo et al., ), and block the transcription factors
  NF-κB (Lee et al., ; Branvall et al., ). III Migration and invasion inhibition:
  statins induce T-cell suppression and B-cell survival (Branvall et al., ), and enhance
  the WT p53-dependent autophagy (Chou et al., ). IV Effects in CSC: statins can reduce
  the expression of Sonic Hedgehog (Shh) and consequently, the migration and invasion
  of cancer cells (Yin et al., ). Other cancerogenic pathways are reviewed in Iannelli
  et al. ().'
papertitle: 'The Innovative Potential of Statins in Cancer: New Targets for New Therapies.'
reftext: Elisabetta Di Bello, et al. Front Chem. 2020;8:516.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8024395
figid_alias: PMC7312214__F1
figtype: Figure
redirect_from: /figures/PMC7312214__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7312214__fchem-08-00516-g0001.html
  '@type': Dataset
  description: '(A) Schematic summary of Mevalonate Pathway (MVP) and chemical structure
    of HMGCR inhibitors mainly studied in cancer (simvastatin, lovastatin, pravastatin,
    fluvastatin, pitavastatin, atorvastatin and rosuvastatin); the pharmacophore moiety
    in red and the ring system moiety in blue). (B) Overview of the main molecular
    targets of statins in cancer. I Antiproliferative effect: statins inhibit the
    proliferation of cancer cell increasing ER stress markers GRP78 and ERp44, phosphorylating
    S6 and 4EBP1 and inhibiting mTOR pathway (Okubo et al., ), and inhibiting HDACs
    (Lin et al., ; Chou et al., ). Statins involve LKB1-AMPK-p38MAPK-p53 survivin
    signaling cascade thanks to the phosphorylation and acetylation of p53 in cancer
    cells (Huang et al., ). II Pro-apoptotic effect: statins enhance apoptosis through
    inhibition of survivin protein expression (see above) (Huang et al., ), by inhibiting
    HIF-1α/PPAR-γ/PKM2-mediated glycolysis (Feng et al., ), induce caspase 3/7/8/9
    protease, decrease the expression of cyclin D1 and CDK4 Bcl-XL (Okubo et al.,
    ), and block the transcription factors NF-κB (Lee et al., ; Branvall et al., ).
    III Migration and invasion inhibition: statins induce T-cell suppression and B-cell
    survival (Branvall et al., ), and enhance the WT p53-dependent autophagy (Chou
    et al., ). IV Effects in CSC: statins can reduce the expression of Sonic Hedgehog
    (Shh) and consequently, the migration and invasion of cancer cells (Yin et al.,
    ). Other cancerogenic pathways are reviewed in Iannelli et al. ().'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ipp
  - Pmvk
  - Ccnd1
  - Bax
  - Nkx3-1
  - Pten
  - Cdk4
  - Trp53
  - Hif1a
  - Pkm
  - Bcl2
  - Nfkb1
  - Erp44
  - Akt1
  - Mdk
  - Ephb2
  - Mapk1
  - Myc
  - Nol3
  - Cdh1
  - Fzr1
  - ras
  - Hras
  - Kras
  - Rem1
  - Apk
  - Rho
  - Rhod
  - Ea2
  - Eif4ebp1
  - Mtor
  - Ccn1
  - Vegfa
  - Pik3r1
  - Mmp9
  - Mapk3
  - Sele
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Sufu
  - Shh
  - Gli1
  - Yap1
  - Tafazzin
  - Wwtr1
  - Nanog
  - Pou5f1
  - IPP
  - CCND1
  - PTEN
  - HIF1A
  - PKLR
  - BCL2
  - ERP44
  - BIRC5
  - MYC
  - CDH1
  - RHO
  - OPN1MSW
  - MTOR
  - CYR61
  - VEGFA
  - MMP9
  - SELE
  - SUFU
  - SHH
  - GLI1
  - TAZ
  - NANOG
  - PMVK
  - BAX
  - CDK4
  - TP53
  - TP63
  - TP73
  - PKM
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - NFKB1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - FZR1
  - KRAS
  - HRAS
  - NRAS
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - EIF4EBP1
  - CCN1
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - YAP1
  - TAFAZZIN
  - WWTR1
  - POU5F1
  - POU5F1P3
  - POU5F1P4
  - CG9784
  - CG9426
  - CG6805
  - Synj
  - INPP5E
  - 5PtaseI
  - mk
  - p53
  - betaTub60D
  - hth
  - sima
  - Debcl
  - Dif
  - dl
  - Rel
  - ERp44
  - Akt
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - shg
  - Ras64B
  - Ras85D
  - Nplp1
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - Thor
  - Tor
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - DCTN6-p27
  - dap
  - CG9588
  - Su(fu)
  - SNF4Agamma
  - AMPKalpha
  - yki
  - Taz
  - Dis3
  - DMAPP
  - Farnesyl
  - Mevalonate
  - Geranyl
  - Squalene
  - Geranylgeranyl
  - Cholesterol
  - Steroids
  - PRO
  - SIMVASTATIN
---
